Represents a naturally occurring active form of MMP-2 which lacks the C-terminal hemopexin domain. MMPs lacking this domain cannot cleave native collagens; however, activity toward other targets such as gelatin, casein, or peptide substrates is unaffected.
Product Details
| Alternative Name: | Matrix metalloproteinase 2, Gelatinase A, 72 kDa Type IV collagenase |
| |
| MW: | ~40kDa |
| |
| Source: | Produced in yeast. Active recombinant matrix metalloproteinase-2 (MMP-2, gelatinase A, 72kDa type IV collagenase) cloned from human cDNA. The enzyme consists of residues Tyr110-Asp452, which comprises the catalytic/fibronectin domain of human MMP-2, with a C-terminal purification tag. |
| |
| UniProt ID: | P08253 |
| |
| Gene/Protein Identifier: | NM_004530 (RefSeq) |
| |
| Formulation: | Liquid. In 50mM TRIS-HCl, pH 7.5, containing 300mM NaCl, 5mM CaCl2, 20µM ZnCl2, 0.05% Brij-35 and 20% glycerol. |
| |
| Purity: | ≥90% (SDS-PAGE) |
| |
| Purity Detail: | Purified by multi-step chromatography. |
| |
| Activity: | Preincubation of MMP-2 catalytic domain at 5nM with the broad-spectrum inhibitor GM6001 (Prod. No. BML-EI300) at 30nM for 1 hour completely inhibits enzymatic activity. |
| |
| Specific Activity: | ≥200 pmol/min/µg at 37°C using the colorimetric thiopeptolide Ac-Pro-Leu-Gly-S-Leu-Leu-Gly-OEt (100 µM; Prod. No. BML-P125) as substrate. |
| |
| Application Notes: | Useful tool to study enzyme kinetics, cleave target substrates, and screen for inhibitors. |
| |
| Shipping: | Dry Ice |
| |
| Long Term Storage: | -80°C |
| |
| Use/Stability: | The enzyme is stable on ice for at least several hours. However, it is recommended that thawing and dilution of the enzyme be done within as short a time as possible before start of the assay. After initial defrost, aliquot product into individual tubes and refreeze at -70°C. Avoid repeated freeze/defrost cycles.
NOTE: When stored under the above conditions, this enzyme is stable at the concentration supplied, in its current storage buffer. Procedures such as dilution of the enzyme followed by refreezing could lead to loss of activity. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Developing Metal-Binding Isosteres of 8-Hydroxyquinoline as Metalloenzyme Inhibitor Scaffolds: H. Seo, et al.; Inorg. Chem.
61, 7631 (2022),
Abstract;
MMP2 and TLRs modulate immune responses in the tumor microenvironment: L.R. Muniz-Bongers, et al.; JCI Insight
6, 144913 (2021),
Abstract;
Overhydroxylation of lysine of collagen increases uterine fibroids proliferation: roles of lysyl hydroxylases, lysyl oxidases, and matrix metalloproteinases: M. Kamel, et al.; Biomed. Res. Int.
2017, 5316845 (2017),
Abstract;
Full Text
Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis: S. Rother, et al.; Acta Biomater.
45, 143 (2016),
Abstract;
Development and validation of novel enzyme activity methods to assess inhibition of matrix metalloproteinases (MMPs) in human serum by antibodies against enzyme therapeutics: T.J. Edkins, et al.; J. Pharm. Biomed. Anal.
70, 408 (2012),
Abstract;
Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex: A.S. Harney, et al.; J. Biol. Inorg. Chem.
17, 853 (2012),
Abstract;
Full Text
Directed evolution of protease beacons that enable sensitive detection of endogenous MT1-MMP activity in tumor cell lines: A. Jabaiah, et al.; Chem. Biol.
18, 392 (2011),
Abstract;
Full Text
Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction: Z. Sahul, et al.; Circ. Cardiovasc. Imaging
4, 381 (2011),
Abstract;
Full Text
Heterogeneity in MT1-MMP activity with ischemia-reperfusion and previous myocardial infarction: relation to regional myocardial function: J.A. Dixon, et al.; Am. J. Physiol. Heart Circ. Physiol.
299, H1947 (2010),
Abstract;
Full Text
Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury: M.A. Ali, et al.; Circulation
122, 2039 (2010),
Application(s): Cleavage of native titin in isolated mouse skinned cardiomyocytes,
Abstract;
Full Text
The effect of a hydroxamic acid-containing polymer on active matrix metalloproteinases: G.A. Skarja, et al.; Biomaterials
30, 1890 (2009),
Abstract;
Related Products
